XML 54 R34.htm IDEA: XBRL DOCUMENT v3.25.4
BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of reportable business segment information
Reportable business segment information for the years ended December 31, 2025 and 2024 is as follows (dollar amounts in thousands):
2025AsiaEuropeNorth AmericaLatin America and OtherTotal
Net sales$221,777 $93,133 $143,611 $21,623 $480,144 
Cost of sales48,484 27,524 48,528 7,884 
Volume incentives71,185 37,359 29,485 6,562 
Selling, general and administrative (1)61,944 20,203 34,736 5,949 
Segment operating income$40,164 $8,047 $30,862 $1,228 $80,301 
Unallocated corporate selling, general and administrative expense(55,558)
Operating income24,743 
Interest and other income, net645 
Interest expense(98)
Foreign exchange gains, net4,522 
Income from operations before provision for income taxes$29,812 

2024AsiaEuropeNorth AmericaLatin America and OtherTotal
Net sales$207,794 $84,837 $138,849 $22,884 $454,364 
Cost of sales48,557 27,836 45,364 7,918 
Volume incentives69,685 33,758 29,773 7,374 
Selling, general and administrative (1)55,443 18,577 32,793 6,299 
Segment operating income$34,109 $4,666 $30,919 $1,293 $70,987 
Unallocated corporate selling, general and administrative expense(50,892)
Operating income20,095 
Interest and other income, net177 
Interest expense(146)
Foreign exchange losses, net(1,700)
Income from operations before provision for income taxes$18,426 
___________________________
(1) Service fees in China totaled $16.8 million and $14.5 million for the years ended December 31, 2025 and 2024, respectively. These service fees are included in selling, general and administrative expenses for our Asia segment.
Year Ended December 31,20252024
Depreciation and amortization:  
Asia$1,896 $1,876 
Europe99 93 
North America11,801 12,204 
Latin America and Other48 46 
Total depreciation and amortization$13,844 $14,219 
Schedule of consolidated net sales revenue by geographical locations
The table below reflects sales based upon the sales location where they occurred. From an individual country/region perspective, the United States, Taiwan, Japan and South Korea comprise 10 percent or more of consolidated net sales for the years ended December 31, 2025 and 2024 as follows (dollar amounts in thousands):
Year Ended December 31,20252024
Net sales:  
United States$133,387 $127,924 
Taiwan67,280 70,579 
Japan56,070 43,940 
South Korea50,842 51,362 
Other172,565 160,559 
Total net sales$480,144 $454,364 
Schedule of revenue generated by each of the Company's product lines
Net sales generated by each product line for the years ended December 31, 2025 and 2024 are as follows (dollar amounts in thousands):
2025AsiaEuropeNorth AmericaLatin America and OtherTotal
General health$83,632$39,794$62,226$6,470$192,122
Immune14,4389,14815,3851,84740,818
Cardiovascular54,55510,80514,6611,61481,635
Digestive47,67324,60141,80410,290124,368
Personal care10,0745,8136,47490623,267
Weight management11,4052,9723,06149617,934
Total net sales by segment$221,777$93,133$143,611$21,623$480,144

2024AsiaEuropeNorth AmericaLatin America and OtherTotal
General health$81,313 $36,631 $59,520 $6,418 $183,882 
Immune12,0528,45415,8022,41638,724
Cardiovascular56,2669,26514,4431,72681,700
Digestive38,95822,74839,32510,713111,744
Personal care5,0325,3976,2411,13317,803
Weight management14,1732,3423,51847820,511
Total net sales by segment$207,794 $84,837 $138,849 $22,884 $454,364 
Schedule of consolidated property, plant and equipment by geographical locations
From an individual country perspective, only the United States has material balances of consolidated property, plant and equipment as follows (dollar amounts in thousands):
As of December 31 20252024
Property, plant and equipment, net  
United States$29,061 $34,786 
Other3,854 4,799 
Total property, plant and equipment, net$32,915 $39,585